Showing 721-730 of 2742 results for "".
MATV News: The Art of Injecting; Chemicals in Beauty Products; Neurotoxin Pipeline
https://modernaesthetics.com/series/matv-news/matv-news-the-art-of-injecting-chemicals-in-beauty-products-neruotoxin-pipeline/33322/A highly detailed body painting project is helping physicians better improve botulinum toxin injection techniques, a new study shows women with skin of color have higher levels of beauty-product related chemicals in their bodies, and a neuromodulator in the pipeline is showing promise. And, a look aTopical Botanicals: Truth and Opportunities
https://modernaesthetics.com/ma-issues-index/2017-july-aug/topical-botanicals-truth-and-opportunities/34252/Botanically-sourced ingredients can support skin repair and health, but much depends on the formulation and the evidence from stringent product testing.Art vs Craft: The Eye Knows
https://modernaesthetics.com/ma-issues-index/2017-may-june/art-vs-craft-the-eye-knows/34275/There's an art to recognizing the deeper impact that procedures and we, as Aesthetic Physicians, have on the self-confidence and happiness of patients we treat.MATV News: Filler Injection Safety; Bullying and Cosmetic Surgery
https://modernaesthetics.com/series/matv-news/matv-news-filler-injection-safety-bullying-and-cosmetic-surgery/33340/Coverage of an expert update on how to avoid facial danger zones when injecting fillers, and a look at how SkinCeuticals and Resurge International are teaming up on a new Pioneering Women in Reconstructive Surgery initiative. Also, the American Society for Laser Medicine and Surgery and the AesthetiThe Rise of Below-the-Belt Surgery
https://modernaesthetics.com/ma-issues-index/2017-mar-apr/the-rise-of-below-the-belt-surgery/34293/A PG-13 rated discussion on cosmetic surgery's final frontier.How Aesthetic Surgeons Can Capitalize on Neglected Sources of Competitive Advantage
https://modernaesthetics.com/ma-issues-index/2017-mar-apr/how-aesthetic-surgeons-can-capitalize-on-neglected-sources-of-competitive-advantage/34294/A few neglected sources of competitive advantage represent significant opportunities for practitioners willing to pioneer new ways to achieve differentiation in an increasingly competitive marketplace.MATV News: Cosmetic Surgery on the Rise; Effects of Submental Fullness
https://modernaesthetics.com/series/matv-news/matv-news-cosmetic-surgery-on-the-rise-effects-of-submental-fullness/33346/Cosmetic surgery is on the rise, and the focus is on the face and fat, according to the American Society of Plastic Surgeons. Also in this episode, Allergan shares results of a new survey to help physicians better understand the impact of a double chin, Galderma and Colorescience team up, and a lookMATV News: Allergan Acquires Zeltiq; The Formula for Attractive Lips
https://modernaesthetics.com/series/matv-news/matv-news-allergan-acquires-zeltiq-the-formula-for-attractive-lips/33348/Acquisitions top aesthetic news with Allergan acquiring Zeltiq and Hologic buying Cynosure along with rumors that Syneron is on the block. What do these acquisitions mean for the field? Also in this episode, new research assesses what measurements create the most attractive female lips and we look aAll In One
https://modernaesthetics.com/ma-issues-index/2017-jan-feb/all-in-one/34312/How one expert distilled diverse training, rich clinical and life experiences, and the challenges of practice management down to a simplified and rewarding approach to aesthetic practice.MATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus Velocity